NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









ClavystBio

ClavystBio

Overview

ClavystBio is a life sciences investor and venture builder established by Temasek that invests in and partners with founders to launch and grow global companies from Singapore. Its focus spans therapeutics, digital health, and medtech, with an emphasis on first-in-class science and technology.

Year Founded

2022

Portfolio Companies

13

Investments

ClavystBio investments
CompanyDateStageLead
Biobot SurgicalJun 2026VC RoundLead
Leyden LabsJun 2026VC RoundCo-investor
Rejoni, Inc.Jun 2026VC RoundCo-investor
Cirrus TherapeuticsOct 2025SeedLead
RespireeJul 2025Series ALead

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersSingapore
Year Founded2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.